Contract Research Organization CRO

About Us

A Legacy of Quality an Integrity

Eurofins Advinus has long been an integral part of the global Eurofins Scientific network. We are a premier preclinical Contract Research Organization (CRO) offering comprehensive contract research services, supported by over 30 years of GLP-compliant experience. Our services cater to diverse industries, including Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical, and Cosmetic sectors.

As part of an internal rebranding aligned with the global corporate structure, Eurofins Advinus is now Eurofins India—reflecting our stronger integration with the extensive Eurofins network and our unified commitment to advancing science worldwide.

We remain dedicated to supporting our clients’ research and development programs with scientific excellence, regulatory rigor, and a customer-focused approach—empowering them to meet global standards and accelerate innovation.

Innovative Research for a Healthier Tomorrow
Driven by Excellence, Guided by Integrity
Transforming Science into Life-saving Solutions
Global Collaboration for Groundbreaking Achievement
Empowering Health with Advanced Biotechnology

OUR SERVICES

WHY CHOOSE US?

Commitment to Quality and Compliance

At Eurofins Advinus, we excel in drug discovery and development with a focus on innovation and client-centered solutions. Our advanced technology and infrastructure drive cutting-edge research, ensuring top quality and compliance. We are a trusted partner in the pharmaceutical and biotechnology industries.

OUR FACILITY TOUR

Advanced Manufacturing Units & Research Centers

Discover our collaborative workspaces that foster teamwork and creativity among our expert scientists and researchers. Take a look at our advanced manufacturing units designed for high-efficiency production and stringent quality control.

TESTIMONIALS

Client Success Stories
Real Results, Real Impact

I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Tarus Therapeutics’ investigational new drug (IND) application for TT-4, a potentially first-in-class, oral Adenosine A2B receptor (A2BR) Antagonist. I commend Eurofins Advinus team for their highest quality of work and professionalism..

I would say that overall our experience with Eurofins Advinus has been very positive at all times. From the perspective of a small biotech like Origo, Eurofins Advinus fulfils all our requirements: flexibility, adherence to pre agreed timelines, adequate quality for the stage of development and no cost deviations!

I would like to thank the entire Advinus team for their tremendous support in the submission of two INDs with the US FDA. The Advinus team performed multiple in vitro and in vivo IND enabling studies with the highest scientific quality while meeting very aggressive timelines.

I would like to thank the entire Advinus team for their hard work and dedication. Recently, we have worked with Advinus on 2 INDs and both have been successfully submitted to US FDA. Advinus team is very dedicated and deliver a high quality reports and SEND data for IND submission. Team communication is excellent and they have very talented individuals with expertise in their field. I look forward to working with Advinus in future projects.